NCT02084888

Brief Summary

The purpose of this study is to determine the prognostic impact of the presence of chronic total occlusions (CTO) of the coronary arteries in patients undergoing coronary angiography and PCI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91,154

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2005

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 10, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 12, 2014

Completed
Last Updated

March 12, 2014

Status Verified

March 1, 2014

Enrollment Period

7 years

First QC Date

March 10, 2014

Last Update Submit

March 11, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • All cause Mortality

    3 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study is based on all patients who underwent diagnostic coronary angiography and were registered in SCAAR during the period 2005 to January 2012 . Only patients who were diagnosed with significant coronary artery disease were included in the analyses.

You may qualify if:

  • Patient with angiographic diagnosis of significant CAD registered in SCAAR between January 2005 and january 2012

You may not qualify if:

  • Previous CABG surgery
  • Missing data on coronary anatomy
  • Patients who underwent a procedure for ACS in whom the 100% occlusion was located in the same coronary artery as the culprit vessel
  • Patients who underwent a procedure in the same vessel within the previous 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahlgrenska University Hospital

Gothenburg, 41345, Sweden

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Truls Råmunddal, MD PhD

    Sahlgrenska University Hospital

    PRINCIPAL INVESTIGATOR
  • Elmir Omerovic, MD PhD

    Sahlgrenska University Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior consultant cardiologist, Director of the catheterization laboratory

Study Record Dates

First Submitted

March 10, 2014

First Posted

March 12, 2014

Study Start

January 1, 2005

Primary Completion

January 1, 2012

Study Completion

January 1, 2012

Last Updated

March 12, 2014

Record last verified: 2014-03

Locations